Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 Feb 23;302(6774):474. doi: 10.1136/bmj.302.6774.474

Ovarian hyperstimulation.

M S Mills, P G Wardle
PMCID: PMC1669362  PMID: 1824018

Full text

PDF

Page 474

474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borenstein R., Elhalah U., Lunenfeld B., Schwartz Z. S. Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. Fertil Steril. 1989 May;51(5):791–795. doi: 10.1016/s0015-0282(16)60668-4. [DOI] [PubMed] [Google Scholar]
  2. Golan A., Ron-El R., Herman A., Weinraub Z., Soffer Y., Caspi E. Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization. Fertil Steril. 1988 Dec;50(6):912–916. doi: 10.1016/s0015-0282(16)60371-0. [DOI] [PubMed] [Google Scholar]
  3. Haning R. V., Jr, Strawn E. Y., Nolten W. E. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol. 1985 Aug;66(2):220–224. [PubMed] [Google Scholar]
  4. Smith B. H., Cooke I. D. Ovarian hyperstimulation: actual and theoretical risks. BMJ. 1991 Jan 19;302(6769):127–128. doi: 10.1136/bmj.302.6769.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Smitz J., Camus M., Devroey P., Erard P., Wisanto A., Van Steirteghem A. C. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod. 1990 Nov;5(8):933–937. doi: 10.1093/oxfordjournals.humrep.a137223. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES